FNS and Weight Support Treadmill Training for Gait Component Restoration
NCT ID: NCT00011596
Last Updated: 2009-01-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
36 participants
INTERVENTIONAL
2000-08-31
2003-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Gait Training For Acute Stroke: Functional Neuromuscular Stimulation (FNS) and Weight Supported Treadmill Training
NCT00101543
Feasibility and Practice Characteristics of FNS and Gait Robot
NCT00508755
Cognitive & Motor Training After Stroke For Everyday Walking Restoration
NCT01160653
A Novel Mechanics-based Intervention to Improve Post-stroke Stability
NCT02964039
Retraining the Walking Pattern After Stroke
NCT03813342
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A total of thirty six chronic stroke patients will be randomly divided into two treatment groups (1) FNS-IM plus BWS; (2) BWS alone. Outcome measures for hypothesis testing will be threefold : 1) Gait normality (kinematics of nine gait components); 2) Safety (number of falls); 3) Functionality (gait speed, walking endurance, and CHART, a handicap measure of mobility and activity level). Data will be collected every four weeks during the three months of treatment. Maintenance of gains will be monitored at two additional data collections at six months and one year following the end of the treatment period. Results of this study have the potential to provide the following clinically applicable information:
1\. For patients with stroke, a refined treatment protocol of 3 months duration for restoration of normal, safe, volitional gait which is practical within the current healthcare milieu. 2. A definitive recommendation regarding the most effective treatment for chronic stroke patients: (1) BWS plus FNS-IM or (2) BWS alone.
RESEARCH OBJECTIVES
1. Build stimulators and electrodes.
2. Obtain measures pre and post intervention for the two groups (FNS-IM + BWS; and BWS alone) to detect gains in: a) gait pattern; b) safety; c) functional capability; and d) quality of life.
3. Analyze data for the group receiving FNS-IM + BWS, in order to test
Hypothesis I.
4. Produce therapy protocols for FNS-IM and BWS intervention, and treatment progression.
5. Test Hypothesis II by comparing the two treatment groups (BWS vs BWS + FNS-IM).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Gait Training
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
US Department of Veterans Affairs
FED
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
John Fryer, Ph.D. Asst. Director
Role:
Department of Veterans Affairs, Program Analysis and Review Section (PARS), Rehabilitation Research & Development service
Nancy Rocheleau, Program Analyst
Role:
Department of Veterans Affairs, Program Analysis and Review Section (PARS), Rehabilitation Research & Development service
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
VAMC, Cleveland
Cleveland, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
B2226R
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.